To confirm that the inhibition of ZIKV replication is caused by the ability of DIPs to stimulate the IFN system, we used the Janus kinase 1/2 (JAK1/2) inhibitor ruxolitinib in co-infection experiments (Figure 5). The gene discussed is JAK1; the disease is infection.